SBIR/STTR Research Award

IGF OT IGF SBIR PHASE I TOPIC COMPACT CELL FREE DNA DETECTION ARRAY

Award identifier 57076728342a14c5562db0713da344949113af11d7d545fdb6be779a452a8225Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$299,999

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOHMICS INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
K39ENMXNLA73
Solicitation number
Not reported
Topic code
NCI

Research abstract

Cell free nucleic acid cfNA biomarkers circulating in the blood have the potential to serve as simple rapid and non invasive diagnostic indicators As such cell free biomarkers have emerged in the forefront of cancer diagnostic research with the promise of improved disease state prognostication therapy resistance monitoring and metastasis or recurrence determination using a simple blood test A multiplexed cancer diagnostic device with the sensitivity to detect low molecular copies of biomarkers of specific cancer genotypes simplicity of blood plasma lateral flow strip assays and robustness of nucleic acid microarrays that can be packaged as a comprehensive genotype cancer diagnostic panel would greatly improve early detection rates of recurrence and metastasis and guide the oncology treatment plan To overcome barriers limiting the adoption of high density microassays in diagnostic settings Arrion Sciences an early stage biotechnology and sensor development subsidiary Austin TX working in collaboration with LC Sciences Houston TX DRS Technologies the University of Texas at Austin Microelectronics Research Center UT MRC and Dr Sylvie Beaudenon Huibregste is proposing to develop a multiplexed biodetection array platform with nucleic acid probes for detection of clinically significant cell free breast cancer biomarkers in the blood

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

306 SBIR/STTR records share this UEI (2003–2025). Reported award amounts total $109,302,435. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, Department of Health and Human Services, Department of Homeland Security, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.